{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:02:14Z","timestamp":1790550134331,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T00:00:00Z","timestamp":1598054400000},"content-version":"am","delay-in-days":418,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ymgme.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T23:50:48Z","timestamp":1560901848000},"page":"184-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Efficacy of low dose nitisinone in the management of alkaptonuria"],"prefix":"10.1016","volume":"127","author":[{"given":"Natacha","family":"Sloboda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Merten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amerh","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Jeannesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Henn-M\u00e9n\u00e9tr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Gu\u00e9ant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Feillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2019.06.006_bb0005","series-title":"Alkaptonuria","year":"1993"},{"key":"10.1016\/j.ymgme.2019.06.006_bb0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jclinpath-2012-200877","article-title":"Recent advances in management of alkaptonuria (invited review; best practice article)","volume":"66","author":"Ranganath","year":"2013","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0015","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s004310050956","article-title":"Effects of ascorbic acid and low-protein diet in alkaptonuria","volume":"157","author":"Mayatepek","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0020","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa021736","article-title":"Natural history of alkaptonuria","volume":"347","author":"Phornphutkul","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2018.07.011","article-title":"Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre","volume":"125","author":"Ranganath","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0030","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003495-200666060-00002","article-title":"Nitisinone in the treatment of hereditary tyrosinaemia type 1","volume":"66","author":"McKiernan","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2019.06.006_bb0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/annrheumdis-2014-206033","volume":"75","author":"Ranganath","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-8-8","article-title":"Recommendations for the management of tyrosinaemia type 1","volume":"8","author":"de Laet","year":"2013","journal-title":"Orphan. J. Rare Dis."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0002-9394(02)01532-5","article-title":"Corneal opacities associated with NTBC treatment","volume":"134","author":"Ahmad","year":"2002","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0050","first-page":"1","article-title":"Reversible keratopathy due to hypertyrosinaemia following intermittent low-dose nitisinone in alkaptonuria: a case report","volume":"17","author":"Stewart","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0055","author":"E.F.S.A. (EFSA)"},{"key":"10.1016\/j.ymgme.2019.06.006_bb0060","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.clinbiochem.2013.12.016","article-title":"Interferences of homogentisic acid (HGA) on routine clinical chemistry assays in serum and urine and the implications for biochemical monitoring of patients with alkaptonuria","volume":"47","author":"Curtis","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cca.2012.10.022","article-title":"Simultaneous detection of diagnostic biomarkers of alkaptonuria, ornithine carbamoyltransferase deficiency, and neuroblastoma disease by high-performance liquid chromatography\/tandem mass spectrometry","volume":"420","author":"Hsu","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2019.06.006_bb0070","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/02688690802226368","article-title":"Alkaptonuria presenting with ochronotic spondyloarthropathy","volume":"22","author":"Al-Mahfoudh","year":"2008","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1016558510123","article-title":"Pregnancy and tyrosinaemia type II","volume":"25","author":"Cerone","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.metabol.2004.12.017","article-title":"Use of nitisinone in patients with alkaptonuria","volume":"54","author":"Suwannarat","year":"2005","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2011.04.016","article-title":"A 3-year randomized therapeutic trial of nitisinone in alkaptonuria","volume":"103","author":"Introne","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10545-016-9979-0","article-title":"Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency","volume":"40","author":"Morris","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0095","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.joca.2018.05.017","article-title":"Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project","volume":"26","author":"Braconi","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0100","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","article-title":"Key European guidelines for the diagnosis and management of patients with phenylketonuria","volume":"5","author":"van Spronsen","year":"2017","journal-title":"Lancet Diabet. Endocrinol."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","article-title":"NTBC treatment in tyrosinaemia type I: long-term outcome in French patients","volume":"31","author":"Masurel-Paulet","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10545-011-9429-y","article-title":"Heterogeneity of follow-up procedures in French and Belgian patients with treated hereditary tyrosinemia type 1: results of a questionnaire and proposed guidelines","volume":"35","author":"Schiff","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0115","author":"FDA"},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2019.06.006_bb0120","doi-asserted-by":"crossref","first-page":"S507","DOI":"10.1007\/s10545-012-9569-8","article-title":"Maternal and fetal tyrosinemia type I","volume":"33","author":"Garcia Segarra","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0125","first-page":"27","article-title":"Pregnancy during nitisinone treatment for tyrosinaemia type I: first human experience","volume":"5","author":"Vanclooster","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0130","first-page":"66","article-title":"Neurological crises after discontinuation of nitisinone (NTBC) treatment in tyrosinemia","volume":"11","author":"Honar","year":"2017","journal-title":"Iran. J. Child Neurol."},{"key":"10.1016\/j.ymgme.2019.06.006_bb0135","doi-asserted-by":"crossref","first-page":"839S","DOI":"10.3945\/an.115.011817","article-title":"Protein and amino acid requirements during pregnancy","volume":"7","author":"Elango","year":"2016","journal-title":"Adv. Nutr."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219302999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219302999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:23:10Z","timestamp":1761088990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219302999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1096719219302999"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.06.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of low dose nitisinone in the management of alkaptonuria","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}